What one share of Incyte holds
Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. Our global headquarters is located in Wilmington, Delaware, where we conduct discovery, clinical development and commercial operations.
Incyte’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $26.43 |
|---|---|
| Profit | $7.06 |
| Capex (buildings and equipment) | $0.32 |
| Free cash flow | $7.15 |
| Cash and investments | $17.31 |
| Book value | $28.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$2.06 | — | — | — | −$0.99 |
| 2010 | $1.40 | −$0.26 | $0.03 | $0.77 | — | −$0.72 |
| 2011 | $0.75 | −$1.49 | $0.03 | −$1.32 | — | −$1.80 |
| 2012 | $2.29 | −$0.34 | $0.02 | −$0.75 | — | −$1.31 |
| 2013 | $2.39 | −$0.56 | $0.03 | $0.03 | — | −$1.18 |
| 2014 | $3.05 | −$0.29 | $0.17 | −$0.01 | — | −$0.48 |
| 2015 | $4.02 | $0.03 | $0.14 | $0.34 | — | $0.92 |
| 2016 | $5.70 | $0.54 | $0.62 | $0.95 | — | $2.22 |
| 2017 | $7.51 | −$1.53 | $0.54 | −$1.00 | — | $7.72 |
| 2018 | $8.73 | $0.51 | $0.34 | $1.22 | — | $9.03 |
| 2019 | $9.92 | $2.05 | $0.36 | $2.91 | — | $12.02 |
| 2020 | $12.23 | −$1.36 | $0.86 | −$1.43 | — | $11.90 |
| 2021 | $13.45 | $4.27 | $0.82 | $2.56 | — | $17.05 |
| 2022 | $15.16 | $1.52 | $0.35 | $3.98 | — | $19.62 |
| 2023 | $16.36 | $2.65 | $0.14 | $2.05 | — | $23.14 |
| 2024 | $20.15 | $0.15 | $0.41 | $1.18 | — | $17.82 |
| 2025 | $25.62 | $6.41 | $0.29 | $6.75 | — | $26.04 |
Common questions about Incyte
How much does one share of Incyte earn?
Over the last 12 months, each share of Incyte earned $7.06 of profit on $26.43 of sales, keeping about 27¢ of every $1 (profit margin).
Does Incyte pay a dividend?
Incyte didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Incyte’s book value per share?
Incyte’s book value is $28.12 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of March 31, 2026.
How much cash and debt does each share of Incyte have?
Each share of Incyte has $17.31 of cash and investments, as of March 31, 2026.
What is Incyte’s free cash flow per share?
$7.15 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Incyte bought back shares?
Incyte’s share count rose about 95% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.